NCT06972563

Brief Summary

This study will be conducted to determine the effects of acceptance and commitment therapy-based psychoeducation on cognitive avoidance levels and coping attitudes in patients diagnosed with generalized anxiety disorder. H0: Acceptance and commitment therapy-based psychoeducation has no effect on the cognitive avoidance levels and coping attitudes of patients diagnosed with generalized anxiety disorder. H1: Acceptance and commitment therapy-based psychoeducation reduces the cognitive avoidance levels of patients diagnosed with generalized anxiety disorder. H2: Acceptance and commitment therapy-based psychoeducation affects the coping attitudes of patients diagnosed with generalized anxiety disorder.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2024

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 25, 2024

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 25, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

September 25, 2024

Completed
8 months until next milestone

First Posted

Study publicly available on registry

May 15, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 25, 2025

Completed
Last Updated

May 15, 2025

Status Verified

April 1, 2025

Enrollment Period

1 month

First QC Date

September 25, 2024

Last Update Submit

May 6, 2025

Conditions

Keywords

Generalized Anxiety DisorderAcceptance and Commitment TherapyCognitive AvoidanceCoping Attitudes

Outcome Measures

Primary Outcomes (1)

  • Measuring the effect of cognitive avoidance levels of patients diagnosed with generalized anxiety disorder

    Patients answered cognitive avoidance scale. Cognitive Avoidance Scale (Cope) measures cognitive avoidance strategies. COA is a self-assessment type scale. The five (1-5) point Likert-type scale (1-strongly disagree, 5-strongly agree) measures 25 items of COA. The score that can be obtained from the scale is between 12 and 125. In order to calculate the total score, it is necessary to sum the answers given to all items. A high score indicates that a cognitive avoidance strategy is used in the face of problems.

    1 month

Secondary Outcomes (1)

  • coping attitudes of patients diagnosed with generalized anxiety disorder

    1 month

Study Arms (2)

Experiment

EXPERIMENTAL

Psychoeducation Based on Acceptance and Commitment Therapy Applied to Patients Diagnosed with Generalized Anxiety Disorder

Other: Psychoeducation Based on Acceptance and Commitment Therapy Applied to Patients Diagnosed with Generalized Anxiety Disorder

Control

OTHER

The initiative was not implemented.

Other: The initiative was not implemented.

Interventions

Psychoeducation Based on Acceptance and Commitment Therapy Applied to Patients Diagnosed with Generalized Anxiety Disorder

Experiment

The initiative was not implemented.

Control

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Having been diagnosed with generalized anxiety disorder according to DSM-5 diagnostic criteria and receiving outpatient treatment
  • Being literate
  • Having no problems understanding or speaking Turkish
  • Being in the 18-65 age group
  • Having not received such training in the last 6 months

You may not qualify if:

  • Those diagnosed with another comorbid mental illness Patients with a mental condition that makes cooperation impossible, such as intellectual disability or memory impairment
  • The illiterate
  • Patients who do not consent to be interviewed

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hatay Eğitim ve Araştırma Hastanesi

Hatay, Antakya, 31030, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Generalized Anxiety Disorder

Condition Hierarchy (Ancestors)

Anxiety DisordersMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Nurse

Study Record Dates

First Submitted

September 25, 2024

First Posted

May 15, 2025

Study Start

June 25, 2024

Primary Completion

July 25, 2024

Study Completion

June 25, 2025

Last Updated

May 15, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

No detailed permission was obtained from the owners of the collected data.

Locations